Related Experiment Videos
Evaluation of methaemalbumin in acute pancreatitis
Abstract:
Methaemalbumin (MHA) was measured in 62 patients with acute pancreatitis. In 26 MHA-positive patients the occurrence of renal and pulmonary complications was 65% and 58%, respectively, compared with 3% and 6% in 36 MHA-negative patients. Fatality rate was 54% in MHA-positive and 6% in MHA-negative patients. In 17 MHA-positive cases haemorrhagic pancreatitis was proven at laparotomy or postmortem examination. Thus MHA determination proved to be a valuable diagnostic and prognostic parameter in acute pancreatitis.
Insights
Methaemalbumin (MHA) presence in acute pancreatitis indicates a higher risk of renal and pulmonary complications, and significantly increases fatality rates. MHA is a valuable prognostic marker for this condition.
Area of Science:
- Biochemistry
- Clinical Medicine
- Medical Diagnostics
Background:
- Acute pancreatitis is a severe condition with significant morbidity and mortality.
- Identifying reliable prognostic markers is crucial for patient management.
Purpose of the Study:
- To evaluate methaemalbumin (MHA) as a diagnostic and prognostic marker in acute pancreatitis.
- To correlate MHA levels with clinical outcomes, including complications and fatality.
Main Methods:
- Methaemalbumin (MHA) levels were measured in 62 patients diagnosed with acute pancreatitis.
- Patients were categorized as MHA-positive or MHA-negative.
- Clinical outcomes, including renal and pulmonary complications and fatality rates, were recorded and compared between groups.
Main Results:
- MHA-positive patients (26) showed significantly higher rates of renal (65%) and pulmonary (58%) complications compared to MHA-negative patients (3% and 6%).
- The fatality rate was substantially higher in MHA-positive patients (54%) versus MHA-negative patients (6%).
- Hemorrhagic pancreatitis was confirmed in 17 MHA-positive cases.
Conclusions:
- Methaemalbumin determination is a valuable prognostic tool in acute pancreatitis.
- MHA positivity is strongly associated with severe complications and increased mortality.
- MHA can aid in risk stratification and clinical decision-making for acute pancreatitis patients.